Skip to main content
. 2018 Jan 15;29(2):84–95. doi: 10.1091/mbc.E17-06-0342

FIGURE 2:

FIGURE 2:

(A) Normal and scleroderma fibroblasts (n = 3, * = p < 0.05 by Student’s t test) treated with IL6xRα and SD1029. (B) The effect of SD1029 on STAT3 Y705 phosphorylation, FN1 protein, and COL1 protein in serum-starved scleroderma lung fibroblasts. (C) The effect of STAT3 down-regulation with siRNA on COL1A2 and EDA–fibronectin mRNA expression in scleroderma lung fibroblasts (n = 3, * = p < 0.05). (D) Serum-starved scleroderma lung fibroblasts were treated with IL6xRα, TGFβ, and SD1029 for 24 h before assaying COL1A2 mRNA levels (n = 3, * = p < 0.05).